BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28315502)

  • 1. The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension.
    Lim HS; Howell N; Ranasinghe A
    Int J Artif Organs; 2017 Mar; 40(2):67-73. PubMed ID: 28315502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
    J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications.
    Lim HS; Zaphiriou A
    J Card Fail; 2016 Feb; 22(2):117-24. PubMed ID: 26547011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation.
    Laimoud M; Hakami E; Maghirang MJ; Mohamed T
    Egypt Heart J; 2023 Dec; 75(1):102. PubMed ID: 38117355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.
    Sugimoto K; Yoshihisa A; Nakazato K; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
    Int Heart J; 2020; 61(2):301-307. PubMed ID: 32224602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.
    Nagy AI; Venkateshvaran A; Merkely B; Lund LH; Manouras A
    Eur J Heart Fail; 2017 Jan; 19(1):88-97. PubMed ID: 27748008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
    Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N
    Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
    Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
    Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.
    Kutty RS; Parameshwar J; Lewis C; Catarino PA; Sudarshan CD; Jenkins DP; Dunning JJ; Tsui SS
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1237-42. PubMed ID: 23345184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic Response to Exercise in Patients Supported by Continuous Flow Left Ventricular Assist Devices.
    Moss N; Rakita V; Lala A; Parikh A; Roldan J; Mitter SS; Anyanwu A; Campoli M; Burkhoff D; Mancini DM
    JACC Heart Fail; 2020 Apr; 8(4):291-301. PubMed ID: 32035893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Vascular Reverse Remodeling After Left Ventricular Assist Device Implantation in Patients With Pulmonary Hypertension.
    Anegawa E; Seguchi O; Mochizuki H; Kuroda K; Doi Nakajima S; Watanabe T; Yanase M; Tadokoro N; Fukushima S; Fujita T; Fukushima N
    ASAIO J; 2023 Feb; 69(2):151-158. PubMed ID: 36716069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.
    Vicenzi M; Deboeck G; Faoro V; Loison J; Vachiery JL; Naeije R
    Int J Cardiol; 2016 Jan; 202():736-40. PubMed ID: 26469553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lvad pump speed increase is associated with increased peak exercise cardiac output and vo
    Vignati C; Apostolo A; Cattadori G; Farina S; Del Torto A; Scuri S; Gerosa G; Bottio T; Tarzia V; Bejko J; Sisillo E; Nicoli F; Sciomer S; Alamanni F; Paolillo S; Agostoni P
    Int J Cardiol; 2017 Mar; 230():28-32. PubMed ID: 28038810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.
    Kramer T; Dumitrescu D; Gerhardt F; Orlova K; Ten Freyhaus H; Hellmich M; Baldus S; Rosenkranz S
    Int J Cardiol; 2019 May; 283():152-158. PubMed ID: 30777406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary exercise test predicts right heart catheterization.
    Correale M; Tricarico L; Ferraretti A; Monaco I; Concilio M; Padovano G; Acanfora G; Di Biase M; Brunetti ND
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29082512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.